Alexis A. Thompson
ASH awarded $150,000 each to eight investigators through the society’s bridge grant program, designed to sustain promising hematologic research proposals that are not funded through NIH.
“Limitations in the federal research budget continue to impact investigators who are submitting proposals for research studies that are deemed meritorious yet are not funded.,” ASH President Alexis A. Thompson, MD, MPH, professor of pediatrics in the division of hematology, oncology and stem cell transplantation at Northwestern Medicine and associate director of equity and minority health at Ann and Robert H. Lurie Children’s Hospital of Chicago, said in a press release. “The ASH bridge grants are critical to advancing this important research while maintaining America’s biomedical workforce and our competitive edge in biopharmaceutical technology.”
The 1-year grants are intended to support researchers who face gaps in multiyear funding.
ASH has presented more than $15 million in bridge grants to 115 investigators since the program’s inception in 2013.
The recipients of the most recent bridge grants are Aniruddha Deshpande, PhD, of Sanford Burnham Prebys Medical Discovery Institute; Elizabeth A. Eklund, MD, of Northwestern University; David W. Essex, MD, of Temple University; Mark D. Fleming, MD, DPhil, of Boston Children’s Hospital; Vahid Afshar-Kharghan, MD, of The University of Texas MD Anderson Cancer Center; Mohamed L. Sorror, MD, of Fred Hutchinson Cancer Research Center; Robert Welner, PhD, of The University of Alabama at Birmingham; and James W. Young, MD, of Memorial Sloan Kettering Cancer Center.